Ambrosino Pasquale, Papa Antimo, Buonauro Agostino, Mosella Marco, Calcaterra Ilenia, Spedicato Giorgio Alfredo, Maniscalco Mauro, Di Minno Matteo Nicola Dario
Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.
Department of Cardiology, Roccadaspide Hospital, Salerno, Italy.
Eur J Clin Invest. 2021 Aug;51(8):e13552. doi: 10.1111/eci.13552. Epub 2021 May 22.
Endothelial dysfunction is a key mechanism in the development of cardiac remodelling and diastolic dysfunction in heart failure with preserved ejection fraction (HFpEF). Flow-mediated (FMD) and nitrate-mediated dilation (NMD) are noninvasive methods to assess endothelial function. We performed a meta-analysis evaluating the impact of HFpEF on FMD and NMD.
PubMed, Web of Science, Scopus and EMBASE databases were systematically searched according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Differences were expressed as mean difference (MD) with 95% confidence intervals (95%CI). The random effects method was used.
A total of seven studies were included in the final analysis, 7 with data on FMD (326 HFpEF patients and 417 controls) and 3 on NMD (185 HFpEF patients and 271 controls). Compared to controls, HFpEF patients showed significantly lower FMD (MD: -1.929; 95%CI: -2.770, -1.088; P < .0001) and NMD values (MD: -2.795; 95%CI: -3.876, -1.715; P < .0001). Sensitivity analyses substantially confirmed results. Meta-regression models showed that increasing differences in E/A ratio (Z-score: -2.002; P = .045), E/E' ratio (Z-score: -2.181; P = .029) and left atrial diameter (Z-score: -1.951; P = .050) were linked to higher differences in FMD values between cases and controls.
Impaired endothelial function can be documented in HFpEF, with the possibility of a direct association between the severity of diastolic and endothelial dysfunction. Targeting endothelial dysfunction through pharmacological and rehabilitation strategies may represent an attractive therapeutic option.
内皮功能障碍是射血分数保留的心力衰竭(HFpEF)中心脏重塑和舒张功能障碍发展的关键机制。血流介导的血管舒张(FMD)和硝酸盐介导的血管舒张(NMD)是评估内皮功能的非侵入性方法。我们进行了一项荟萃分析,以评估HFpEF对FMD和NMD的影响。
根据系统评价和荟萃分析的首选报告项目(PRISMA)指南,系统检索了PubMed、Web of Science、Scopus和EMBASE数据库。差异以平均差(MD)和95%置信区间(95%CI)表示。采用随机效应模型。
最终分析共纳入7项研究,7项有FMD数据(326例HFpEF患者和417例对照),3项有NMD数据(185例HFpEF患者和271例对照)。与对照组相比,HFpEF患者的FMD值(MD:-1.929;95%CI:-2.770,-1.088;P <.0001)和NMD值(MD:-2.795;95%CI:-3.876,-1.715;P <.0001)显著降低。敏感性分析基本证实了结果。荟萃回归模型显示,E/A比值(Z值:-2.002;P = 0.045)、E/E'比值(Z值:-2.181;P = 0.029)和左心房直径(Z值:-1.951;P = 0.050)差异的增加与病例组和对照组之间FMD值的更高差异相关。
HFpEF患者存在内皮功能障碍,舒张功能障碍和内皮功能障碍的严重程度之间可能存在直接关联。通过药物和康复策略靶向内皮功能障碍可能是一种有吸引力的治疗选择。